Andy Weyer DPT, PhD Coauthors Study

Dr. Andy Weyer co-authored a study examining the effects of a novel pharmacological antagonist of the Transient Receptor Potential Ankyrin 1 (TRPA1) ion channel, which plays a role in pain sensation. The project was completed in collaboration with researchers at Amgen in Thousand Oaks, California and the Medical College of Wisconsin. The paper was accepted for publication by the journal Molecular Pain in November 2016.

Full citation information is listed below:

Lehto SG, Weyer AD, Youngblood BD, Zhang M, Yin R, Wang W, Teffera Y, Cooke M, Stucky CL, Schenkel L, Geuns-Meyer S, Moyer BD, Wild KD, and Gavva NR. Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats. Mol Pain. 2016 Nov 29;12. doi: 10.1177/1744806916677761. PMID: 27899696